Division of Clinical Research

Office of the Vice President and Innovation

Category results for:

Recently Posted FDA Guidance Documents

8/7/2019 – Fabry Disease: Developing Drugs for Treatment Guidance for Industry [DRAFT] Issued by: Center for Drug Evaluation and Research The purpose of this guidance is to provide recommendations to sponsors regarding clinical trial design features that can support the approval of drugs and biological products intended for the treatment of Fabry disease (FD). 7/31/2019 […]

Sept. 11-12: FDA 2019 Science Forum

Transforming Health: Innovation in FDA Science www.fda.gov/scienceforum Dates: September 11-12, 2019 Location: Silver Spring, MD (and webcast) Forum Topic Areas include: Precision Health: Research exploring topics that may enable precision health for individuals and special populations such as sex differences, the microbiome, personalized modeling, genetics, computational modeling, and in vitro/in vivo assessment of an individual’s […]

« Previous Page

Follow this blog